Pharmaceutical firm Novo Nordisk will start production of the weight loss pill Wegovy at its Monksland facilityAthlone firm planning to expand to facilitate production of weight loss drugPharmaceutical firm Novo Nordisk has announced that it will manufacture the weight loss drug Wegovy in tablet form at its Monksland facility. The company intends to expand its manufacturing facility in Athlone to facilitate production of the drug, Novo Nordisk CEO Mike Doustdar told Bloomberg media in an interview. The tablets will be manufactured at the firm's Athlone base for markets outside the United States. Only last year Novo Nordisk announced 115 redundancies at its plant in Athlone. The Wegovy tablet was launched in the United States in January with approximately 240,000 people using the product to date.

Source: Irish Independent February 12, 2026 21:52 UTC